These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7611753)

  • 1. [Clinical evaluation of anticancer effect of methionine-depleting total parenteral nutrition with 5-fluorouracil and/or mitomycin C].
    Goseki N; Maruyama M; Nagai K; Kando F; Endo M; Shimoju K; Wada Y
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1028-35. PubMed ID: 7611753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (surgery group evaluation)].
    Taguchi T; Kosaki G; Onodera T; Endo M; Nakagawara G; Sano K; Kaibara N; Kakegawa T; Nakano S; Kurihara M
    Gan To Kagaku Ryoho; 1995 May; 22(6):753-64. PubMed ID: 7755383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (internal medicine group evaluation)].
    Kitamura S; Ohtani T; Kurihara M; Kosaki G; Akazawa S; Sasaki T; Takahashi H; Nakano S; Tokunaga K
    Gan To Kagaku Ryoho; 1995 May; 22(6):765-75. PubMed ID: 7755384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality of life in patients with advanced gastric cancer receiving AO-90, a methionine-free intravenous amino acid solution, with 5-fluorouracil and mitomycin C].
    Kurihara M; Kosaki G; Taguchi T; Akazawa S; Sasaki T; Takahashi H; Onodera T; Endo M; Nakagawara G; Sano K
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):911-23. PubMed ID: 7793997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early phase II study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90 Study group].
    Sugihara K; Auther C; Mori S; Nishihira T; Matsumoto T; Kawachi S; Ishikawa M; Takahashi M; Nakajima T; Kosaki G
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2405-13. PubMed ID: 2124434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: a randomized, prospective clinical trial.
    Goseki N; Yamazaki S; Shimojyu K; Kando F; Maruyama M; Endo M; Koike M; Takahashi H
    Jpn J Cancer Res; 1995 May; 86(5):484-9. PubMed ID: 7790321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mechanism of potentiation of the antitumor effect of 5-fluorouracil by methionine-free intravenous amino acid solution (AO-90) in rats].
    Hibino Y; Kawarabayashi Y; Kohri H; Ueda N; Tsukagoshi S
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2021-8. PubMed ID: 8085853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
    Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of preoperative parenteral nutritional support with chemotherapy on tumor cell kinetics in gastric cancer patients].
    Cao WX; Xiao HB; Yin HR
    Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):137-40. PubMed ID: 7924865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer].
    Yamamura Y; Nishimura M; Sakamoto J; Yasui K; Morimoto T; Kato T; Yasue M; Kito T; Miyaishi S; Nakazato H
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2134-40. PubMed ID: 3087293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postoperative adjuvant chemotherapy using NCS (neocarzinostatin) and 5-FU in the treatment of gastric cancer. First report--A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU].
    Yokomori T; Taniguchi T; Iesato H; Sakata Y; Watanabe T; Kawabe K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3064-70. PubMed ID: 2960267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous venous infusion of 5-fluorouracil (5-FU) under total parenteral nutrition (TPN) in advanced gastric cancer].
    Tane S; Ogawa Y; Kido Y; Ogawa M; Shiozaki H; Miyamoto T; Kokunai I; Watase M; Mori T
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2322-6. PubMed ID: 3935052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methionine-deprived amino acid solution-induced biochemical modulation of 5-FU and augmentation of the antitumor activity].
    Maeta M; Kaibara N; Sugihara K
    Gan To Kagaku Ryoho; 1992 May; 19(5):618-23. PubMed ID: 1580636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of intraarterial infusion chemotherapy for liver metastasis from gastric cancer FEM: combination therapy of 5-FU, epirubicin and MMC].
    Takada J; Katsuki Y; Hamada H; Tsuji Y
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1627-30. PubMed ID: 14619480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of intra-arterial infusion chemotherapy for liver metastasis from gastric cancer].
    Hashimoto M; Tsuji Y; Tomita I; Kon H; Sasaki R; Kawata S; Hamada H; Katsuki Y; Yasuda T
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1715-8. PubMed ID: 9382514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of intra-arterial infusion chemotherapy for advanced gastric cancer].
    Kosaka T; Ueshige N; Sugaya J; Nakano Y; Akiyama T; Tomita F; Saito H; Kita I; Takashima S
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1288-91. PubMed ID: 9703810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
    Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
    Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin].
    Murakami M; Morikawa A; Okabe R; Hayashi K; Miyazawa K; Iijima S; Ozaki K; Suzuki A; Koyama Y; Sugiyama A
    Gan To Kagaku Ryoho; 2002 May; 29(5):767-70. PubMed ID: 12040682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PMC (pharmacokinetic modulating chemotherapy) for advanced gastric cancer].
    Fujiwara Y; Kusunoki M; Nakagawa K; Nakao K; Itoh R; Yamamura T
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2175-81. PubMed ID: 10635301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
    Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
    Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.